Tag: Immune Disorders
Risk for Autoimmune Inflammatory Rheumatic Disease Increased After SARS-CoV-2
Increased risk seen for incident AIRD for patients with SARS-CoV-2, with higher risk seen after more severe acute COVID-19
CAR T-Cell Therapy Feasible, Safe for Autoimmune Diseases
Beneficial outcomes seen for patients with systemic lupus erythematosus, idiopathic inflammatory myositis, systemic sclerosis
Incidence of Autoimmune Disease Increased After Surgical Remission of Cushing
Incidence of new-onset autoimmune disease higher compared with those with nonfunctioning pituitary adenomas
Link Between Inflammatory Disease, Adverse Pregnancy Outcomes Varies
Patients with IMIDs had increased risk for PTB, LBW, SGA, C-section overall, but variation seen by disease, comorbidities
Prolonged SARS-CoV-2 Risk Varies Across Immunosuppressive Conditions
Severely immunocompromised individuals had greater SARS-CoV-2 evolution, higher risk for developing resistance against therapeutic mAbs
Study IDs Risks to Offspring Associated With Prenatal Opioid Exposure
Prenatal opioid exposure linked to increased risk for infection, eczema and dermatitis, and asthma in offspring
Bidirectional Link ID’d for Autoimmune Disease, Perinatal Depression
Bidirectional association more pronounced among women without psychiatric comorbidities, strongest for multiple sclerosis
Disease-Modifying Antirheumatic Drugs May Cut Incidence of Autoimmune Thyroid Disease
Findings seen among adults after diagnosis with rheumatoid arthritis
Fourth COVID-19 Shot Beneficial in Patients With Autoimmune Rheumatic Diseases
Fourth dose reduces risk for SARS-CoV-2 for patients with systemic autoimmune rheumatic diseases using DMARDs
ACR: Incidence of Atrioventricular Block Increased With High Levels of Anti-SSA/Ro Antibodies
Incidence of atrioventricular block increased with higher antibody levels, reaching 7.7 percent in top quartile of anti-60 kD SSA-Ro
